M&A Deal Summary |
|
|---|---|
| Date | 2023-03-27 |
| Target | Jounce Therapeutics |
| Sector | Life Science |
| Buyer(s) | Concentra Biosciences |
| Deal Type | Merger |
SEARCH BY
Try For Free 7-Day Free Trial
Concentra Biosciences is a biosciences company that serves clients around the US. Concentra Biosciences is based in San Diego, California.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector (Life Science) | 1 of 2 |
| Type (Merger) | 1 of 1 |
| State (Massachusetts) | 1 of 2 |
| Country (United States) | 1 of 2 |
| Year (2023) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-12-22 |
Theseus
Cambridge, Massachusetts, United States Theseus is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies. The company is focused on the development of THE-349, a fourth-generation, selective epidermal growth factor receptor inhibitor for C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer, a pan-variant BCR-ABL inhibitor for the treatment of relapsed/refractory chronic myeloid leukemia and newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia, and a next-generation, highly selective, pan-variant KIT inhibitor for the treatment of early-line GIST. Theseus is based in Cambridge, Massachusetts. |
Buy | - |
